Issues: August 27, 2024
Virtual Asthma KSA Group Study Set for October 13
The OAFP will hold an Asthma KSA virtually on October 13. Registration is open and is limited to the first 45 OAFP members to register. Don’t miss this opportunity to complete a virtual KSA and earn 8 CME credits and 10 ABFM points! Read More
Dr. Mike Sevilla Receives Prestigious Torchlight Leadership Award
“I’m honored and humbled by this recognition. As a family physician, all I have ever wanted to do is to promote health and wellness to my patients and to my community…” Read More
Seeking Member Feedback on Resolution to Monitor Opioid Prescriptions to Pets
The OAFP is seeking feedback on the “resolved” portions of the Monitor Opioid Prescriptions to Pets resolution. The deadline for comments is September 25. Read More
Weekly Government Relations Briefing
In this week’s issue: lawsuit filed over redistricting ballot language; AAFP’s August Family Medicine Advocacy Rounds; H.R. 1770 opposition letter; and Ohio’s 24-hour abortion waiting period on hold over constitutionality lawsuit. Read More
OAFP Honors Family Physicians for 50 Years in Medicine
Please join the OAFP in proudly recognizing 22 members who have been part of the medical profession for 50 years this year. Read More
AAFP’s 2024 Proposed Resolutions Open for Member Comment; Deadline September 3
All members are encouraged to review the 2024 proposed resolutions and submit written testimony no later than Tuesday, September 3, directly on each resolution’s webpage. Member login is required. Read More
OAFP Foundation Board Seeks Trustees
The OAFP Foundation is seeking fearless and determined family physicians that are up for building a strong and thriving family medicine workforce for Ohio, to serve on its Board of Trustees! Application deadline is September 30. Read More
Pharmacy Board Seeks Comments on Proposed Immunization Rules
The Pharmacy Board proposes the adoption of amended rules on immunizations. Comments are due by September 18. Read More
FDA Approves New COVID Vaccines, Prepares for Rollout
The FDA has approved this year’s updated COVID-19 vaccines, designed to target the KP.2 strain of the SARS-CoV-2 virus, from Moderna and Pfizer. Read More



